1-7 of 7
jak2 gene v617f
Close
Sort by
Journal Articles

Patients with triple-negative, JAK2 V617F- and CALR -mutated essential thrombocythemia share a unique gene expression signature

Samah Alimam, William Villiers, Richard Dillon, Michael Simpson, Manohursingh Runglall, Alexander Smith, Prodromos Chatzikyriakou, Paul Lavender, Anju Kanda, Ken Mills, Beatriz Bellosillo Paricio, James Kaufman-Cook, Sophie Ord, Shahram Kordasti, Deepti Radia, Claire Woodley, Yvonne Francis, Ghulam Mufti, Donal P. McLornan, Claire N. Harrison
Journal: Blood Advances
Blood Adv (2021) 5 (4): 1059–1068.
https://doi.org/10.1182/bloodadvances.2020003172
Published: 2021
Includes: Supplemental data
Journal Articles

JAK2 S523L, a novel gain-of-function mutation in a critical autoregulatory residue in JAK2 V617F − MPNs

Friederike Pastore, Aishwarya Krishnan, Henrik M. Hammarén, Olli Silvennoinen, Benedict Yan, Ross L. Levine
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4554–4559.
https://doi.org/10.1182/bloodadvances.2019001283
Published: 2020
Includes: Supplemental data
Journal Articles

Sex determines the presentation and outcomes in MPN and is related to sex-specific differences in the mutational burden

Clinical Trials & Observations
Theodoros Karantanos, Shruti Chaturvedi, Evan M. Braunstein, Jerry Spivak, Linda Resar, Styliani Karanika, Donna M. Williams, Ophelia Rogers, Christopher D. Gocke, Alison R. Moliterno
Journal: Blood Advances
Blood Adv (2020) 4 (12): 2567–2576.
https://doi.org/10.1182/bloodadvances.2019001407
Published: 2020
Includes: Supplemental data
Journal Articles

Thrombotic, inflammatory, and HIF-regulated genes and thrombosis risk in polycythemia vera and essential thrombocythemia

Radhika Gangaraju, Jihyun Song, Soo Jin Kim, Tsewang Tashi, Brandi N. Reeves, Krishna M. Sundar, Perumal Thiagarajan, Josef T. Prchal
Journal: Blood Advances
Blood Adv (2020) 4 (6): 1115–1130.
https://doi.org/10.1182/bloodadvances.2019001379
Published: 2020
Journal Articles

N -acetylcysteine inhibits thrombosis in a murine model of myeloproliferative neoplasm

Brianna M. Craver, Gajalakshmi Ramanathan, Summer Hoang, Xinyue Chang, Laura F. Mendez Luque, Stefan Brooks, Hew Yeng Lai, Angela G. Fleischman
Journal: Blood Advances
Blood Adv (2020) 4 (2): 312–321.
https://doi.org/10.1182/bloodadvances.2019000967
Published: 2020
Includes: Supplemental data
Journal Articles

Hmga2 collaborates with JAK2 V617F in the development of myeloproliferative neoplasms

Koki Ueda, Kazuhiko Ikeda, Takayuki Ikezoe, Kayo Harada-Shirado, Kazuei Ogawa, Yuko Hashimoto, Takahiro Sano, Hiroshi Ohkawara, Satoshi Kimura, Akiko Shichishima-Nakamura, Yuichi Nakamura, Yayoi Shikama, Tsutomu Mori, Philip J. Mason, Monica Bessler, Soji Morishita, Norio Komatsu, Kotaro Shide, Kazuya Shimoda, Shuhei Koide, Kazumasa Aoyama, Motohiko Oshima, Atsushi Iwama, Yasuchika Takeishi
Journal: Blood Advances
Blood Adv (2017) 1 (15): 1001–1015.
https://doi.org/10.1182/bloodadvances.2017004457
Published: 2017
Includes: Supplemental data
Journal Articles

JAK2 V617F hematopoietic clones are present several years prior to MPN diagnosis and follow different expansion kinetics

Thomas McKerrell, Naomi Park, Jianxiang Chi, Grace Collord, Thaidy Moreno, Hannes Ponstingl, Joao Dias, Petroula Gerasimou, Kiki Melanthiou, Chrystalla Prokopiou, Marios Antoniades, Ignacio Varela, Paul A. Costeas, George S. Vassiliou
Journal: Blood Advances
Blood Adv (2017) 1 (14): 968–971.
https://doi.org/10.1182/bloodadvances.2017007047
Published: 2017
Includes: Supplemental data